AMES: Strong Rally Needs Deeper Pullback Before the Next BullisAlexandria New Medical Center Co.EGX_DLY:AMESmnmabroukw36ix📊 AMES: Strong Rally Needs Deeper Pullback Before the Next Bullish Wave ⚕️ 🏛️ Fundamental Review: 📊 Business Quality: AMES is a leading private healthcare provider on the Egyptian Exchange, operating integrated hospital, surgical, and diagnostic facilities in Alexandria. The company benefits from the defensive nature of the healthcare sector and is backed by strong institutional shareholders. 🏥 ✅ Strengths & Catalysts: The company continues to improve its operating performance, delivering double-digit revenue growth and recovering profit margins. 📈 Healthcare remains one of the most defensive sectors, allowing AMES to maintain resilient demand regardless of economic cycles. 🛡️ Institutional ownership exceeding 96% provides long-term financial stability and supports future expansion plans. 🏆 ⚠️ Risks: The extremely low free float limits liquidity and can result in sharp price movements during periods of low trading activity. ⚠️ Operations remain exposed to imported medical equipment and foreign exchange fluctuations. 💱 The stock currently trades at premium valuation multiples, leaving less room for earnings disappointments. 📉 🕌 Sharia Compliance: 🟡 AMES operates in a Sharia-permissible healthcare business. However, sufficient public financial data is currently unavailable to conclusively verify compliance with the latest EGX33 Sharia financial screening criteria. ☪️ 💰 Valuation: Although the company's business quality remains attractive, the recent rally has pushed the stock above its historical valuation range, making technical entry timing increasingly important. 💎 🔍 The Pulse: AMES experienced exceptional liquidity over the past month, driving the stock into a parabolic advance that reached a new all-time high near 144.94 EGP. 🚀 Following that rally, the stock entered a healthy correction and retraced toward the Fibonacci 38.2% level around 107.00 EGP. 📉 Last week confirmed that the correction is still underway. 📊 Despite the current pullback, I remain bullish over the medium term because the exceptional institutional and retail liquidity suggests the long-term trend remains intact. 💪 My long-term technical target remains around 245.00 EGP if the broader bullish structure continues. 🎯 However, momentum and volume indicators remain significantly overbought, suggesting the correction has not yet fully matured. ⚠️ I would prefer to wait for a deeper retracement toward the Fibonacci 61.8% level around 83.50 EGP before considering new entries. 📍 That area offers a much more attractive risk-to-reward opportunity for medium-term investors. ✅ 🧱 The Key Structural Boundaries 📍 Preferred Entry Zone, 83.50 EGP. The Fibonacci 61.8% retracement represents the preferred accumulation area. ⚠️ Current Outlook. The correction appears incomplete while momentum indicators remain overheated. 🎯 Long-Term Target, 245.00 EGP. The primary medium-term objective if the long-term bullish trend resumes. 🛑 Stop Loss, 66.00 EGP. A confirmed close below this level invalidates the current bullish structure. 🎯 The Verdict: AMES remains one of the stronger healthcare names on the EGX with improving operational performance and strong institutional backing. 🏥 The recent correction should be viewed as a healthy reset following a parabolic rally rather than a deterioration in fundamentals. 📈 Patience is warranted, as waiting for the Fibonacci 61.8% retracement around 83.50 EGP provides a significantly more attractive entry than chasing the current price. 🎯 Maintain disciplined risk management with a stop loss below 66.00 EGP. 🛡️ --- If you like my insights, follow and boost! 🙌💙🚀 🎁 $15 TradingView Discount: https://www.tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑